MedPath

Adenosine

Adenosine Injection, USP

Approved
Approval ID

6785cf30-360f-409b-a4b2-fc910728f01f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 4, 2018

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Adenosine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-651
Application NumberANDA205568
Product Classification
M
Marketing Category
C73584
G
Generic Name
Adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 20, 2018
FDA Product Classification

INGREDIENTS (2)

ADENOSINEActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.